BRAF and metastatic melanoma: In this study, a new potent anticancer compound with concentration- and mainly time-dependent antiproliferative effects on two cutaneous metastatic melanoma (CMM) BRAF mutant cell lines, has been identified in a TPP-based bola amphiphile (BPPB), already reported for its antibacterial effects against MDR clinical isolates of ESKAPE bacteria.